Is Ceritinib/Ceritinib a targeted drug or a chemotherapy drug and analysis of the difference

Ceritinib (Ceritinib) is a targeted drug rather than a traditional chemotherapy drug. It mainly acts on patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer. By specifically inhibiting ALK tyrosine kinase activity, it blocks the growth and proliferation signals of tumor cells, thereby achieving anti-tumor effects. This is significantly different from the mechanism of action of traditional chemotherapy drugs. Chemotherapy drugs usually kill rapidly proliferating cells, including normal tissue cells, by destroying cell DNA or interfering with cell division, and have relatively large side effects.

The advantage of targeted drugs lies in the precision of treatment. Seritinib targets tumor cells with ALK gene rearrangements or mutations. It has a significant effect on patients with these specific molecular abnormalities, but has less impact on normal cells. Therefore, the adverse reactions are milder than chemotherapy drugs. In contrast, chemotherapy drugs have a broad spectrum of effects and are difficult to distinguish between tumor cells and healthy cells. Therefore, side effects such as hair loss, bone marrow suppression, and gastrointestinal reactions often occur.

In clinical application, ceritinib is usually used for patients with advanced or metastatic ALK-positive non-small cell lung cancer, especially for patients who are resistant to first-line ALK inhibitors or who are intolerant to other ALK inhibitors. Chemotherapy drugs can be used for a wider range of tumor types, but their efficacy depends on the proliferation rate and sensitivity of the tumor, and the treatment cycle is long and side effects management is complicated.

Generally speaking, ceritinib is a precision targeted therapy drug, which is characterized by a clear mechanism, specific action target, and relatively low toxic and side effects, while chemotherapy drugs are non-specific anti-tumor drugs with a wide range of killing but relatively large side effects. When selecting a treatment plan, the doctor will make a reasonable decision to use targeted drugs or chemotherapy drugs based on the patient's genetic test results, disease stage, and tolerance to achieve the best treatment effect.

Reference materials:https://www.drugs.com/